Mucuna pruriens (velvet bean)
Natural L-DOPA source with preliminary RCT signal in early Parkinson's disease, used in Ayurveda as kapikacchu for nervine support.
Why
Mucuna pruriens seed contains 4–7% L-dopa (levodopa) by weight, the standard pharmaceutical treatment for Parkinson's disease. The Cilia 2017 Neurology RCT (n=18 early PD) compared Mucuna with standard levodopa + carbidopa and found comparable motor-symptom benefit with fewer dyskinesias. Smaller bodies support use for fertility, mood, and sleep in Ayurvedic and modern preliminary research. Use in PD must be under specialist supervision; self-management is not appropriate.
How it works
Direct L-dopa content crosses the blood-brain barrier and is decarboxylated to dopamine, same final pharmacology as pharmaceutical levodopa. Additional bioactives (5-HTP precursors, prenylated flavonoids) modulate serotonin and monoamine systems.
Expected onset · Motor symptom effect within hours (acute, like pharmaceutical L-dopa); long-term outcomes assessed over months
How to take
Dosage
Pharmacological PD doses use 30 g of Mucuna seed powder = ~250 mg L-dopa per dose. Lower 'nervine' doses: 1–5 g/day standardised extract.
Timing
Divided doses for PD use, like pharmaceutical levodopa
On the label
Stated L-dopa content (typically 10–20% for standardised extract; 4–7% in raw seed powder). Pharmaceutical-grade preferred for therapeutic use.
Ideal for
Adults with early Parkinson's disease in close clinical supervision (specialist context); people exploring Ayurvedic nervine support, with awareness that this is pharmacologically active.
Safety
Evidence
Cilia 2017 Neurology crossover RCT (n=18 early PD): single doses of Mucuna seed powder produced motor improvement comparable to levodopa+carbidopa with fewer dyskinesias. Shukla 2009 Fertil Steril RCT (n=60 infertile men) reported improved seminal parameters at 5 g/day for 3 months. Preliminary evidence, no Cochrane review, EMA HMPC monograph or EFSA-authorised health claim covers this indication; cited RCTs are small or in non-tier-1 journals. Useful as honest reference rather than evidence-grade recommendation.
Preliminary evidence, no Cochrane review, EMA HMPC monograph or EFSA-authorised health claim covers this indication; cited RCTs are small or in non-tier-1 journals. Useful as honest reference rather than evidence-grade recommendation.
Where to get it
Shop Mucuna pruriens (velvet bean) on AmazonSponsored · As an Amazon Associate, Healicus earns from qualifying purchases.